{"gene":"SSRP1","run_date":"2026-06-10T07:46:41","timeline":{"discoveries":[{"year":1999,"finding":"FACT complex is a heterodimer of human SPT16 (hSpt16) and SSRP1; it acts as a chromatin-specific transcription elongation factor, interacts with nucleosomes and histone H2A/H2B dimers, and promotes nucleosome disassembly to facilitate transcription elongation through chromatin templates in vitro. FACT activity is abrogated by covalently crosslinking nucleosomal histones.","method":"Biochemical purification, in vitro transcription reconstitution on chromatin templates, nucleosome binding assays, crosslinking experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro on chromatin, multiple orthogonal biochemical methods, foundational paper replicated by many subsequent studies","pmids":["10421373"],"is_preprint":false},{"year":2001,"finding":"SSRP1 (as part of FACT, a heterodimer with hSpt16) forms a UV-activated kinase complex with CK2 that selectively phosphorylates p53 at Ser-392 in vitro. FACT alters the substrate specificity of CK2 such that it preferentially phosphorylates p53 over other CK2 substrates including casein. Phosphorylation by this complex enhances p53 transcriptional activity.","method":"Biochemical purification of UV-activated kinase complex, in vitro kinase assay, identification of complex components by mass spectrometry/sequencing","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase reconstitution with purified complex, multiple biochemical methods, confirmed in two papers (PMID 11239457 and 12393879)","pmids":["11239457"],"is_preprint":false},{"year":2002,"finding":"hSPT16 and SSRP1 interact via non-overlapping domains in vitro and in cells; binding of hSPT16 and SSRP1 to CK2 changes CK2 conformation to specifically target p53 Ser-392 over other substrates. UV irradiation induces assembly of the CK2·hSPT16·SSRP1 complex, increasing specificity of CK2 for p53 at Ser-392.","method":"Co-immunoprecipitation, in vitro binding assays, domain mapping, in vitro kinase assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and in vitro binding with domain mapping, single lab but orthogonal methods","pmids":["12393879"],"is_preprint":false},{"year":2001,"finding":"The FACT complex (SSRP1/Spt16 heterodimer) exhibits affinity and specificity for cisplatin-damaged DNA, binding the major 1,2-d(GpG) intrastrand adduct. The isolated SSRP1 subunit alone fails to form discrete high-affinity complexes with cisplatin-modified DNA, suggesting Spt16 primes SSRP1 for cisplatin-damaged DNA recognition by unveiling its HMG domain. The isolated HMG domain of SSRP1 alone is sufficient for specific binding to cisplatin-damaged DNA.","method":"Gel mobility shift assays (EMSA) with cisplatin-damaged DNA, testing FACT complex, isolated SSRP1, and isolated HMG domain","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding assays with multiple constructs and controls, single lab","pmids":["11344167"],"is_preprint":false},{"year":2003,"finding":"CK2 phosphorylates maize SSRP1 at multiple C-terminal residues including two sites adjacent to the HMG box domain; this phosphorylation induces a conformational change in the HMG box region (detected by circular dichroism) and switches on recognition of UV-damaged DNA by SSRP1 (non-phosphorylated SSRP1 does not discriminate between UV-damaged and control DNA).","method":"In vitro kinase assay with CK2α, acetic acid-urea PAGE, mass spectrometry phosphosite mapping, circular dichroism, DNA binding assays with UV-damaged DNA","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro phosphorylation with site mapping and structural/functional readout, single lab with multiple orthogonal methods","pmids":["12571244"],"is_preprint":false},{"year":2005,"finding":"CK2 phosphorylates SSRP1 at serines 510, 657, and 688 in vitro; phosphorylation inhibits the nonspecific DNA-binding activity of SSRP1 and FACT. Ser-510 is the most critical site for this regulation. SSRP1 is also phosphorylated in cells in response to UV (but not gamma) irradiation.","method":"In vitro CK2 kinase assay, peptide array kinase assay, site-directed mutagenesis (S510A/S657A/S688A), EMSA DNA-binding assays, metabolic 32P-labeling in cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, functional DNA-binding assay, and in-cell confirmation; single lab but multiple orthogonal methods","pmids":["15659405"],"is_preprint":false},{"year":2002,"finding":"SSRP1 functions as a co-activator of p63 by direct physical interaction (in vitro and in cells); it binds p63γ through its central domain, and ectopic expression of full-length SSRP1 (but not deletion mutants) enhances p63γ-dependent transcription, G1 arrest, apoptosis, and expression of endogenous p53 target genes. SSRP1 co-occupies p53-responsive elements of MDM2 and p21 promoters with p63γ.","method":"Co-immunoprecipitation, in vitro GST pulldown, luciferase reporter assays, chromatin immunoprecipitation (ChIP), cell-based gain/loss-of-function","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, in vitro pulldown, ChIP, and functional reporter assays, single lab","pmids":["12374749"],"is_preprint":false},{"year":1999,"finding":"SSRP1 interacts with SRF (serum response factor) through the MADS box of SRF and a basic region of SSRP1 (amino acids 489–542 adjacent to the HMG domain); this interaction dramatically increases the DNA-binding activity of SRF and results in synergistic transcriptional activation of SRF-dependent promoters. SSRP1 itself does not bind the CArG box.","method":"Yeast one-hybrid screen, co-immunoprecipitation in mammalian cells, EMSA, luciferase reporter assays, domain mapping","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast one-hybrid, Co-IP in mammalian cells, EMSA, reporter assays; single lab with multiple methods","pmids":["10336466"],"is_preprint":false},{"year":1999,"finding":"CHD1 interacts in vivo with SSRP1 via an amino-terminal segment of CHD1 that does not include the chromodomain; CHD1 and SSRP1 co-localize in mammalian nuclei and at transcriptionally active regions of Drosophila polytene chromosomes.","method":"Co-immunoprecipitation (in vivo), immunocytochemistry/immunofluorescence co-localization","journal":"Chromosoma","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with domain mapping and co-localization, single lab","pmids":["10199952"],"is_preprint":false},{"year":2001,"finding":"In yeast, the bipartite FACT analog composed of Cdc68 (Spt16), Pob3, and Nhp6 functionally recapitulates the vertebrate FACT complex; Nhp6 (the yeast functional analog of the SSRP1 HMG domain) associates with the CP complex and provides HMG box functions for transcription elongation. An artificial Pob3-Nhp6a fusion protein (mimicking SSRP1) restores both Pob3 and Nhp6a functions.","method":"Genetic epistasis (double mutant analysis), 6-azauracil sensitivity, protein fusion complementation, co-immunoprecipitation","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with multiple double mutants and protein fusion complementation, single lab","pmids":["11313475"],"is_preprint":false},{"year":2003,"finding":"Ssrp1 homozygous knockout in mice causes embryonic lethality at day 3.5, with preimplantation blastocysts defective for cell outgrowth/survival in vitro. This lethality is p53-independent (crosses with p53-null background do not rescue), establishing nonredundant, essential functions for SSRP1 in early cell viability.","method":"Gene targeting in mouse ES cells, germline transmission, embryo outgrowth assays, p53-null genetic background cross","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with clear phenotype, genetic epistasis with p53-null background, in vivo and ex vivo confirmation","pmids":["12861016"],"is_preprint":false},{"year":2007,"finding":"SSRP1 has both SPT16-dependent and SPT16-independent roles in transcription regulation in human cells; approximately 1.3% of assayed genes are co-regulated by both SSRP1 and Spt16, while a distinct subset is regulated by SSRP1 alone. Both SSRP1 and Spt16 are required for progression of elongating RNA Pol II on the egr1 gene.","method":"Spotted microarray after siRNA knockdown of SSRP1 or Spt16, chromatin immunoprecipitation for elongating Pol II","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide expression profiling plus ChIP for mechanistic follow-up, single lab","pmids":["17209051"],"is_preprint":false},{"year":2009,"finding":"SSRP1 physically interacts with the HR repair protein Rad54 both in vitro and in vivo; SSRP1 inhibits Rad54-promoted branch migration of Holliday junctions in vitro. Knockdown of SSRP1 increases HR frequency and Rad51/H2AX foci, while overexpression reduces HU-induced Rad51 foci, indicating SSRP1 suppresses inappropriate homologous recombination repair.","method":"Co-immunoprecipitation (in vivo), in vitro pulldown, branch migration assay with Holliday junctions, hprt recombination assay, immunofluorescence for Rad51/γH2AX foci, siRNA knockdown and overexpression","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro functional assay (branch migration) plus Co-IP and cell-based epistasis, single lab","pmids":["19639603"],"is_preprint":false},{"year":2009,"finding":"SSRP1 (as a FACT subunit) binds the KSHV latent origin replication element and forms a complex with LANA at this origin; siRNA knockdown of SSRP1 significantly reduces the efficiency of LANA-dependent latent DNA replication.","method":"Biotinylated DNA pulldown/affinity purification to identify origin-binding proteins, Co-immunoprecipitation, siRNA knockdown with plasmid replication efficiency assay","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — DNA affinity pulldown, Co-IP, and functional replication assay after knockdown, single lab","pmids":["19710137"],"is_preprint":false},{"year":2006,"finding":"SSRP1 is cleaved during apoptosis by caspase 3 and/or caspase 7 at the DQHD450 site, generating a truncated chromatin-associated form of FACT. The N-terminal cleavage product is subsequently degraded via the ubiquitin-proteasome pathway (stabilized by proteasome inhibitors and ubiquitylated in cells).","method":"In vitro caspase cleavage assay, site-directed mutagenesis of caspase site, proteasome inhibitor treatment, ubiquitylation assay in cells, cellular fractionation","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro caspase assay with mutagenesis, proteasome inhibitor, and ubiquitylation in cells; single lab with multiple methods","pmids":["16498457"],"is_preprint":false},{"year":2015,"finding":"Crystal structure of the SSRP1 middle domain reveals tandem pleckstrin homology (PH) domains (PH1 with an extra conserved βαβ topology); the middle domain participates in DNA binding via a positively charged patch on its surface, but does not bind histones (negative result confirmed by pulldown assay).","method":"X-ray crystallography, DNA binding assays, histone pulldown assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with functional validation by binding assays; single lab but structure plus biochemistry","pmids":["26687053"],"is_preprint":false},{"year":2015,"finding":"FACT components SUPT16H and SSRP1 suppress HIV-1 transcription and promote viral latency; SUPT16H (but not SSRP1) directly interacts with HIV-1 Tat protein, yet both are recruited to the HIV-1 LTR promoter. SUPT16H interferes with association of Cyclin T1 (a P-TEFb subunit) with the Tat-LTR axis. Depletion of either SSRP1 or SUPT16H spontaneously reverses HIV-1 latency.","method":"RNAi functional genomic screen, Co-immunoprecipitation, HIV-1 LTR reporter assay, ChIP, latency reversal assays in U1/HIV, J-LAT cells, and primary CD4+ T cell model","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP, functional reporter and latency reversal assays with multiple cell models; single lab","pmids":["26378236"],"is_preprint":false},{"year":2017,"finding":"SSRP1 is recruited to DNA single-strand break (SSB) sites in a PARP-dependent manner and is retained at damage sites via N-terminal interactions with XRCC1. SSRP1 (but not SPT16) is specifically required for chromatin decondensation and histone H2B exchange at SSB sites, which primes chromatin for efficient SSB repair and cell survival after ionizing radiation or MMS treatment.","method":"Live-cell imaging (laser microirradiation recruitment), co-immunoprecipitation, domain mutational analysis, siRNA knockdown with survival assay, histone exchange (FRAP), chromatin decondensation assay","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (live imaging, Co-IP, mutagenesis, FRAP, survival assays), clear mechanistic dissection of SSRP1 vs SPT16 roles","pmids":["28416484"],"is_preprint":false},{"year":2018,"finding":"SSRP1 forms an elongated homodimer in solution (characterized by AUC and SAXS); homodimerization involves the PH2 region, the same surface used for heterodimerization with SPT16, suggesting homo- and heterodimerization are mutually exclusive. SSRP1 homodimerization promotes binding to both histones H2A-H2B and H3-H4 (isothermal titration calorimetry); disruption of homodimerization decreases histone-binding affinity.","method":"Analytical ultracentrifugation (AUC), small-angle X-ray scattering (SAXS), isothermal titration calorimetry (ITC), site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — biophysical structural characterization (AUC, SAXS) combined with thermodynamic binding assay (ITC) and mutagenesis; single lab but multiple rigorous methods","pmids":["29764934"],"is_preprint":false},{"year":2020,"finding":"SSRP1 promotes replication origin assembly on somatic chromatin in Xenopus by evicting histone H1 via its N-terminal domain; histone H1 removal derepresses ORC and MCM chromatin binding, enabling efficient replication origin firing. SSRP1 protein decays at mid-blastula transition (MBT), and increased SSRP1 levels delay MBT and accelerate post-MBT cell cycle speed and embryo development.","method":"Xenopus laevis egg extract replication assays, chromatin fractionation, siRNA/antibody depletion of SSRP1 and H1, domain mutational analysis, embryo microinjection","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution in Xenopus extracts with domain mutant analysis, chromatin fractionation, and in vivo embryo experiments; multiple orthogonal approaches","pmids":["32165637"],"is_preprint":false},{"year":2016,"finding":"Depletion of SSRP1 in human mesenchymal stem cells decreases expression of osteoblast-specific genes and downregulates Wnt pathway target genes, accompanied by decreased nuclear localization of active β-catenin, identifying a role for SSRP1 in promoting Wnt signaling pathway activity during osteoblast differentiation.","method":"siRNA knockdown in human MSCs, RNA-seq, Western blot for active β-catenin nuclear localization, differentiation assays","journal":"Stem cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-seq combined with protein localization data after knockdown; single lab, two orthogonal methods","pmids":["27146025"],"is_preprint":false},{"year":2024,"finding":"TRIB3 directly interacts with SSRP1 and USP10, forming a TRIB3/USP10/SSRP1 ternary complex; USP10-mediated deubiquitination stabilizes SSRP1 protein, and TRIB3 enhances this deubiquitinating effect. A stapled peptide (SP-A) disrupts the TRIB3/USP10/SSRP1 complex and promotes SSRP1 degradation.","method":"Co-immunoprecipitation, ubiquitination assays, in vivo and in vitro interaction studies, peptide disruption assay","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with mechanistic follow-up (ubiquitination assay and pharmacological disruption), single lab","pmids":["39653795"],"is_preprint":false},{"year":1998,"finding":"SSRP1 (identified as PREIIBF) binds with sequence specificity to a 19-bp positive regulatory element (PRE II) in the human embryonic ε-globin gene promoter, bends the target DNA, and is required for promoter activation in stable erythroid cell lines. This is the first evidence that SSRP1 plays a direct role in transcriptional regulation via sequence-specific DNA binding.","method":"cDNA expression cloning, EMSA (gel shift with specific DNA competition), DNA bending assay (circularization), stable transfection reporter assay in erythroid cells","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA with competition controls, DNA bending assay, stable cell reporter assay; single lab with multiple methods","pmids":["9566881"],"is_preprint":false},{"year":2023,"finding":"SSRP1 maintains mitochondrial oxidative respiration in hepatocellular carcinoma cells by transcriptionally promoting expression of TRAP1 (the mitochondrial HSP90 family member); SSRP1 occupies the TRAP1 promoter (by ChIP), and SSRP1 knockdown decreases TRAP1 mRNA and protein, reduces mitochondrial oxidative respiration, and causes mitochondrial damage.","method":"siRNA knockdown, ChIP assay, qRT-PCR, Western blot, mitochondrial respiration assay (Seahorse), rescue experiments","journal":"Biochemistry and cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus functional rescue experiments confirming transcriptional mechanism; single lab","pmids":["37084412"],"is_preprint":false},{"year":2024,"finding":"The FACT complex (hSpt16/SSRP1) mediates the FEAR (FACT-ETS-1 Antiviral Response) pathway, remodeling chromatin to activate expression of the antiviral transcription factor ETS-1 to restrict RNA virus (VSV and paramyxovirus) replication. VSV M protein promotes proteasome-dependent degradation of SUMOylated hSpt16 to counter FEAR; this antagonism of SUMOylated Spt16 by viral proteins is a conserved mechanism across DNA and RNA viruses.","method":"siRNA depletion of hSpt16/SSRP1, viral replication assays, mutant M protein analysis, genetic rescue experiments","journal":"bioRxiv (preprint)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with defined replication phenotype, mutant virus rescue, preprint not yet peer-reviewed","pmids":["bio_10.1101_2024.08.22.609092"],"is_preprint":true}],"current_model":"SSRP1 is an essential histone chaperone subunit of the FACT complex (heterodimer with SPT16) that facilitates chromatin transcription elongation and replication by interacting with nucleosomes and H2A/H2B dimers to promote nucleosome disassembly; it also forms an elongated homodimer (via its PH2 domain) capable of binding H2A-H2B and H3-H4 independently of SPT16, participates in DNA single-strand break repair through PARP-dependent recruitment and XRCC1 interaction at damage sites, suppresses inappropriate homologous recombination by inhibiting Rad54-mediated branch migration, promotes replication origin assembly in vertebrate embryos by evicting histone H1 via its N-terminal domain, modulates p53 Ser-392 phosphorylation by altering CK2 substrate specificity (with CK2-mediated phosphorylation of SSRP1 itself at Ser-510/657/688 inhibiting its DNA-binding activity), acts as a co-activator of p63 and SRF transcription factors through direct protein interactions, suppresses HIV-1 and HTLV-1 transcription as part of the FACT-ETS-1 (FEAR) antiviral pathway, and is degraded during apoptosis by sequential caspase-3/7 cleavage at Asp-450 followed by ubiquitin-proteasome-mediated proteolysis."},"narrative":{"mechanistic_narrative":"SSRP1 is an essential histone chaperone that, as one subunit of the heterodimeric FACT complex with SPT16, binds nucleosomes and histone H2A/H2B dimers to drive nucleosome disassembly and facilitate RNA polymerase II elongation through chromatin [PMID:10421373, PMID:17209051]. Its essentiality is intrinsic and p53-independent: homozygous loss is lethal at the mouse blastocyst stage [PMID:12861016]. The protein is built from defined modules — a middle region of tandem pleckstrin-homology domains that contributes DNA binding but not histone binding [PMID:26687053], and a PH2 surface that mediates either heterodimerization with SPT16 or, mutually exclusively, formation of an elongated SSRP1 homodimer that binds both H2A-H2B and H3-H4 independently of SPT16 [PMID:29764934]. Beyond transcription elongation, SSRP1 carries out SPT16-independent chromatin functions: it is recruited to DNA single-strand breaks in a PARP-dependent manner, retained through N-terminal XRCC1 interactions, and required for chromatin decondensation and H2B exchange that prime single-strand break repair [PMID:28416484]; it suppresses inappropriate homologous recombination by binding Rad54 and inhibiting Holliday-junction branch migration [PMID:19639603]; and it promotes replication origin assembly by evicting histone H1 via its N-terminal domain to derepress ORC/MCM loading [PMID:32165637]. SSRP1 also acts in transcription factor–directed gene control, serving as a co-activator of p63 [PMID:12374749] and SRF [PMID:10336466] and as a sequence-specific activator of the embryonic ε-globin promoter [PMID:9566881], and it modulates p53 by reprogramming CK2 substrate specificity toward p53 Ser-392, while reciprocal CK2 phosphorylation of SSRP1 at Ser-510/657/688 inhibits its DNA binding [PMID:11239457, PMID:15659405]. The protein is regulated by competing post-translational programs: caspase-3/7 cleavage at Asp-450 followed by ubiquitin-proteasome degradation during apoptosis [PMID:16498457], and USP10-mediated deubiquitination within a TRIB3/USP10/SSRP1 complex that stabilizes it [PMID:39653795]. Through its FACT-resident chromatin-remodeling activity, SSRP1 additionally participates in antiviral and viral-replication control, restricting HIV-1 transcription and supporting KSHV latent replication [PMID:26378236, PMID:19710137].","teleology":[{"year":1998,"claim":"Established that SSRP1 can act directly in transcription through sequence-specific DNA binding, before its chromatin chaperone role was defined.","evidence":"cDNA cloning, EMSA, DNA bending, and erythroid reporter assays at the ε-globin PRE II element","pmids":["9566881"],"confidence":"Medium","gaps":["Does not connect sequence-specific binding to the later-defined FACT nucleosome activity","No structural basis for PRE II recognition"]},{"year":1999,"claim":"Defined SSRP1 as half of the FACT heterodimer that disassembles nucleosomes to enable transcription elongation, the core function of the protein.","evidence":"Biochemical purification and in vitro transcription reconstitution on chromatin with nucleosome binding and crosslinking assays","pmids":["10421373"],"confidence":"High","gaps":["Did not resolve which subunit contacts which histone surface","In vitro chromatin templates only"]},{"year":1999,"claim":"Identified SSRP1 partnerships beyond SPT16, linking it to SRF-dependent transcription and to the remodeler CHD1.","evidence":"Yeast one-hybrid, Co-IP, EMSA, reporter assays (SRF) and in vivo Co-IP with co-localization (CHD1)","pmids":["10336466","10199952"],"confidence":"Medium","gaps":["Whether these interactions occur within FACT or via free SSRP1 unresolved","No structural model of the SRF or CHD1 contact"]},{"year":2001,"claim":"Revealed that SSRP1/FACT reprograms CK2 substrate specificity toward p53 Ser-392 and recognizes damaged DNA, expanding its role into the DNA-damage/p53 axis.","evidence":"UV-activated kinase complex purification with in vitro kinase assays; EMSA with cisplatin-damaged DNA using FACT, isolated SSRP1, and the HMG domain","pmids":["11239457","11344167"],"confidence":"High","gaps":["In vitro kinase context only","Functional consequence of damaged-DNA binding for repair not directly tested"]},{"year":2002,"claim":"Mapped the molecular logic of FACT subunit interaction and CK2 conformational steering, and established SSRP1 as a p63 transcriptional co-activator.","evidence":"Domain-mapped Co-IP and in vitro kinase assays (CK2 complex); reciprocal Co-IP, GST pulldown, ChIP, and reporter/phenotype assays (p63γ)","pmids":["12393879","12374749"],"confidence":"Medium","gaps":["Single-lab interaction mapping","Endogenous stoichiometry of the CK2·SPT16·SSRP1 complex unknown"]},{"year":2003,"claim":"Demonstrated SSRP1 is genetically essential for early embryonic viability independent of p53, separating its core function from its p53-modulating role.","evidence":"Mouse gene targeting, embryo outgrowth assays, and crosses to a p53-null background","pmids":["12861016"],"confidence":"High","gaps":["Lethality precludes assignment to a single molecular process","Which essential activity (elongation vs replication) drives lethality not defined"]},{"year":2005,"claim":"Established reciprocal regulation: CK2 phosphorylation of SSRP1 at Ser-510/657/688 inhibits its DNA-binding activity, a UV-responsive control point.","evidence":"In vitro CK2 kinase assays, site-directed mutagenesis, EMSA, and in-cell 32P labeling (with supporting maize data on HMG-adjacent phosphosites)","pmids":["15659405","12571244"],"confidence":"High","gaps":["Cellular consequences of phospho-inhibition for transcription/repair not directly tested","Cross-species site correspondence inferred"]},{"year":2006,"claim":"Showed SSRP1 is dismantled during apoptosis by ordered caspase cleavage and proteasomal degradation, linking FACT inactivation to cell death.","evidence":"In vitro caspase cleavage with site mutagenesis, proteasome inhibitor and ubiquitylation assays, and fractionation","pmids":["16498457"],"confidence":"Medium","gaps":["Functional consequence of the truncated chromatin-bound form not defined","Which apoptotic signals trigger this in vivo unclear"]},{"year":2007,"claim":"Distinguished SPT16-dependent from SPT16-independent SSRP1 transcriptional functions genome-wide.","evidence":"Microarray after siRNA of SSRP1 or Spt16 plus ChIP for elongating Pol II on egr1","pmids":["17209051"],"confidence":"Medium","gaps":["Mechanism of SSRP1-only gene regulation not resolved","Direct vs indirect targets not separated"]},{"year":2009,"claim":"Extended SSRP1 into genome maintenance and viral DNA replication: suppression of homologous recombination via Rad54 and support of KSHV latent origin replication.","evidence":"Co-IP and in vitro branch-migration assay with recombination/foci readouts (Rad54); DNA affinity pulldown, Co-IP, and replication assays (KSHV origin/LANA)","pmids":["19639603","19710137"],"confidence":"Medium","gaps":["Whether HR suppression requires FACT or free SSRP1 unclear","Single-lab functional assays"]},{"year":2015,"claim":"Provided structural and biophysical definition of SSRP1 architecture: a DNA-binding tandem-PH middle domain and a PH2-mediated homodimer that binds histones independently of SPT16.","evidence":"X-ray crystallography with DNA/histone binding assays; AUC, SAXS, ITC, and mutagenesis","pmids":["26687053","29764934"],"confidence":"High","gaps":["In vivo prevalence and function of the homodimer not established","How homo/heterodimer switching is controlled in cells unknown"]},{"year":2017,"claim":"Defined an SPT16-independent role for SSRP1 in single-strand break repair, recruited via PARP and retained by XRCC1 to remodel chromatin for repair.","evidence":"Laser microirradiation live imaging, Co-IP, domain mutants, FRAP histone exchange, and survival assays","pmids":["28416484"],"confidence":"High","gaps":["Direct vs PARP-bridged SSRP1–XRCC1 contact not fully resolved","Relationship to FACT elongation activity unclear"]},{"year":2020,"claim":"Showed SSRP1 promotes replication origin assembly by N-terminal eviction of histone H1, derepressing ORC/MCM loading and timing developmental cell-cycle transitions.","evidence":"Xenopus egg-extract replication assays, chromatin fractionation, depletion, domain mutants, and embryo microinjection","pmids":["32165637"],"confidence":"High","gaps":["Whether mammalian somatic origins use the same H1-eviction mechanism untested","Selectivity of H1 over other linker histones not defined"]},{"year":2024,"claim":"Identified post-translational stabilization of SSRP1 through a TRIB3/USP10 deubiquitination complex, and broadened its FACT-dependent antiviral role through the FEAR/ETS-1 pathway.","evidence":"Co-IP, ubiquitination and peptide-disruption assays (TRIB3/USP10); siRNA depletion, viral replication, and mutant M-protein rescue (FEAR, preprint)","pmids":["39653795","bio_10.1101_2024.08.22.609092"],"confidence":"Medium","gaps":["FEAR finding is a non-peer-reviewed preprint","Whether SSRP1 vs SPT16 drives FEAR chromatin remodeling not separated"]},{"year":null,"claim":"It remains unresolved how SSRP1 partitions between its FACT-bound elongation role, its SPT16-independent repair/replication/homodimer activities, and its many transcription-factor co-activator functions within a single cell.","evidence":"","pmids":[],"confidence":"Low","gaps":["No in vivo measurement of the relative abundance of FACT heterodimer vs SSRP1 homodimer","No unified model linking phospho-regulation, dimer state, and functional choice"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[0,18]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[3,15,22]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[6,7,22,23]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[0,17]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,11]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[12,17]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[19]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,17,19]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[14]}],"complexes":["FACT complex"],"partners":["SUPT16H","CSNK2A1","XRCC1","RAD54","TP63","SRF","CHD1","USP10"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q08945","full_name":"FACT complex subunit SSRP1","aliases":["Chromatin-specific transcription elongation factor 80 kDa subunit","Facilitates chromatin transcription complex 80 kDa subunit","FACT 80 kDa subunit","FACTp80","Facilitates chromatin transcription complex subunit SSRP1","Recombination signal sequence recognition protein 1","Structure-specific recognition protein 1","hSSRP1","T160"],"length_aa":709,"mass_kda":81.1,"function":"Component of the FACT complex, a general chromatin factor that acts to reorganize nucleosomes. The FACT complex is involved in multiple processes that require DNA as a template such as mRNA elongation, DNA replication and DNA repair. During transcription elongation the FACT complex acts as a histone chaperone that both destabilizes and restores nucleosomal structure. It facilitates the passage of RNA polymerase II and transcription by promoting the dissociation of one histone H2A-H2B dimer from the nucleosome, then subsequently promotes the reestablishment of the nucleosome following the passage of RNA polymerase II. The FACT complex is probably also involved in phosphorylation of 'Ser-392' of p53/TP53 via its association with CK2 (casein kinase II). Binds specifically to double-stranded DNA and at low levels to DNA modified by the antitumor agent cisplatin. May potentiate cisplatin-induced cell death by blocking replication and repair of modified DNA. Also acts as a transcriptional coactivator for p63/TP63","subcellular_location":"Nucleus; Nucleus, nucleolus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q08945/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/SSRP1","classification":"Common Essential","n_dependent_lines":1206,"n_total_lines":1208,"dependency_fraction":0.9983443708609272},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000149136","cell_line_id":"CID001040","localizations":[{"compartment":"chromatin","grade":3},{"compartment":"nucleoplasm","grade":3},{"compartment":"nuclear_punctae","grade":2},{"compartment":"nucleolus_gc","grade":2}],"interactors":[{"gene":"COMMD2","stoichiometry":10.0},{"gene":"DKC1","stoichiometry":10.0},{"gene":"RANBP2","stoichiometry":10.0},{"gene":"RSL1D1","stoichiometry":10.0},{"gene":"HIST2H3A","stoichiometry":10.0},{"gene":"ERH","stoichiometry":10.0},{"gene":"TRA2B","stoichiometry":10.0},{"gene":"HIST2H2BE;HIST1H2BB;HIST1H2BO;HIST1H2BJ","stoichiometry":10.0},{"gene":"SUPT16H","stoichiometry":10.0},{"gene":"ZCCHC8","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/target/CID001040","total_profiled":1310},"omim":[{"mim_id":"616933","title":"FORTY-TWO-THREE DOMAIN-CONTAINING PROTEIN 1; FYTTD1","url":"https://www.omim.org/entry/616933"},{"mim_id":"609798","title":"NIMA-RELATED KINASE 9; NEK9","url":"https://www.omim.org/entry/609798"},{"mim_id":"606486","title":"CHARGED MULTIVESICULAR BODY PROTEIN 1B; CHMP1B","url":"https://www.omim.org/entry/606486"},{"mim_id":"605012","title":"SPT16 HOMOLOG, FACILITATES CHROMATIN REMODELING SUBUNIT; SUPT16H","url":"https://www.omim.org/entry/605012"},{"mim_id":"604328","title":"STRUCTURE-SPECIFIC RECOGNITION PROTEIN 1; SSRP1","url":"https://www.omim.org/entry/604328"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Centrosome","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SSRP1"},"hgnc":{"alias_symbol":["FACT80"],"prev_symbol":[]},"alphafold":{"accession":"Q08945","domains":[{"cath_id":"2.30.29.30","chopping":"3-98","consensus_level":"high","plddt":85.2966,"start":3,"end":98},{"cath_id":"2.30.29.220","chopping":"110-186","consensus_level":"high","plddt":80.8782,"start":110,"end":186},{"cath_id":"2.30.29.150","chopping":"199-326","consensus_level":"high","plddt":90.312,"start":199,"end":326},{"cath_id":"2.30.29.30","chopping":"340-420","consensus_level":"high","plddt":90.1217,"start":340,"end":420}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q08945","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q08945-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q08945-F1-predicted_aligned_error_v6.png","plddt_mean":74.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SSRP1","jax_strain_url":"https://www.jax.org/strain/search?query=SSRP1"},"sequence":{"accession":"Q08945","fasta_url":"https://rest.uniprot.org/uniprotkb/Q08945.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q08945/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q08945"}},"corpus_meta":[{"pmid":"10421373","id":"PMC_10421373","title":"The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins.","date":"1999","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/10421373","citation_count":462,"is_preprint":false},{"pmid":"11239457","id":"PMC_11239457","title":"A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1.","date":"2001","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/11239457","citation_count":254,"is_preprint":false},{"pmid":"11313475","id":"PMC_11313475","title":"A bipartite yeast SSRP1 analog comprised of Pob3 and Nhp6 proteins modulates transcription.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11313475","citation_count":108,"is_preprint":false},{"pmid":"12393879","id":"PMC_12393879","title":"p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12393879","citation_count":104,"is_preprint":false},{"pmid":"10199952","id":"PMC_10199952","title":"CHD1 interacts with SSRP1 and depends on both its chromodomain and its ATPase/helicase-like domain for proper association with chromatin.","date":"1999","source":"Chromosoma","url":"https://pubmed.ncbi.nlm.nih.gov/10199952","citation_count":97,"is_preprint":false},{"pmid":"11344167","id":"PMC_11344167","title":"Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatin.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11344167","citation_count":79,"is_preprint":false},{"pmid":"12374749","id":"PMC_12374749","title":"SSRP1 functions as a co-activator of the transcriptional activator p63.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12374749","citation_count":78,"is_preprint":false},{"pmid":"12571244","id":"PMC_12571244","title":"Protein kinase CK2 phosphorylates the high mobility group domain protein SSRP1, inducing the recognition of UV-damaged DNA.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12571244","citation_count":58,"is_preprint":false},{"pmid":"26755331","id":"PMC_26755331","title":"SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497.","date":"2016","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/26755331","citation_count":57,"is_preprint":false},{"pmid":"17209051","id":"PMC_17209051","title":"Human SSRP1 has Spt16-dependent and -independent roles in gene transcription.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17209051","citation_count":57,"is_preprint":false},{"pmid":"12861016","id":"PMC_12861016","title":"The high-mobility-group box protein SSRP1/T160 is essential for cell viability in day 3.5 mouse embryos.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12861016","citation_count":57,"is_preprint":false},{"pmid":"11425313","id":"PMC_11425313","title":"Differential chromatin association and nucleosome binding of the maize HMGA, HMGB, and SSRP1 proteins.","date":"2001","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11425313","citation_count":51,"is_preprint":false},{"pmid":"15659405","id":"PMC_15659405","title":"CK2 phosphorylates SSRP1 and inhibits its DNA-binding activity.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15659405","citation_count":49,"is_preprint":false},{"pmid":"26378236","id":"PMC_26378236","title":"FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26378236","citation_count":45,"is_preprint":false},{"pmid":"10336466","id":"PMC_10336466","title":"Cooperative transcriptional activation by serum response factor and the high mobility group protein SSRP1.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10336466","citation_count":44,"is_preprint":false},{"pmid":"30762286","id":"PMC_30762286","title":"SSRP1 promotes colorectal cancer progression and is negatively regulated by miR-28-5p.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30762286","citation_count":43,"is_preprint":false},{"pmid":"28416484","id":"PMC_28416484","title":"SSRP1 Cooperates with PARP and XRCC1 to Facilitate Single-Strand DNA Break Repair by Chromatin Priming.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/28416484","citation_count":40,"is_preprint":false},{"pmid":"19639603","id":"PMC_19639603","title":"A role for SSRP1 in recombination-mediated DNA damage response.","date":"2009","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19639603","citation_count":34,"is_preprint":false},{"pmid":"26687053","id":"PMC_26687053","title":"Crystal Structure of Human SSRP1 Middle Domain Reveals a Role in DNA Binding.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26687053","citation_count":34,"is_preprint":false},{"pmid":"10929132","id":"PMC_10929132","title":"DNA-interactions and nuclear localisation of the chromosomal HMG domain protein SSRP1 from maize.","date":"2000","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10929132","citation_count":33,"is_preprint":false},{"pmid":"40514727","id":"PMC_40514727","title":"Therapeutic potential of miR-204-5p in intervertebral disc degeneration: targeting the SSRP1/NF-κB pathway to inhibit apoptosis.","date":"2025","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/40514727","citation_count":32,"is_preprint":false},{"pmid":"7862532","id":"PMC_7862532","title":"Identification of a cDNA for SSRP1, an HMG-box protein, by interaction with the c-Myc oncoprotein in a novel bacterial expression screen.","date":"1995","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/7862532","citation_count":32,"is_preprint":false},{"pmid":"27146025","id":"PMC_27146025","title":"Histone Chaperone SSRP1 is Essential for Wnt Signaling Pathway Activity During Osteoblast Differentiation.","date":"2016","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/27146025","citation_count":31,"is_preprint":false},{"pmid":"9566881","id":"PMC_9566881","title":"The HMG domain protein SSRP1/PREIIBF is involved in activation of the human embryonic beta-like globin gene.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9566881","citation_count":30,"is_preprint":false},{"pmid":"19710137","id":"PMC_19710137","title":"Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus.","date":"2009","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/19710137","citation_count":25,"is_preprint":false},{"pmid":"29048646","id":"PMC_29048646","title":"SSRP1 silencing inhibits the proliferation and malignancy of human glioma cells via the MAPK signaling pathway.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/29048646","citation_count":23,"is_preprint":false},{"pmid":"29953487","id":"PMC_29953487","title":"Uncovering the fine print of the CreERT2-LoxP system while generating a conditional knockout mouse model of Ssrp1 gene.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29953487","citation_count":21,"is_preprint":false},{"pmid":"35844005","id":"PMC_35844005","title":"Exosomes loaded with circPARD3 promotes EBV-miR-BART4-induced stemness and cisplatin resistance in nasopharyngeal carcinoma side population cells through the miR-579-3p/SIRT1/SSRP1 axis.","date":"2022","source":"Cell biology and toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/35844005","citation_count":20,"is_preprint":false},{"pmid":"32165637","id":"PMC_32165637","title":"SSRP1-mediated histone H1 eviction promotes replication origin assembly and accelerated development.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32165637","citation_count":17,"is_preprint":false},{"pmid":"30616889","id":"PMC_30616889","title":"A novel lncRNA LOC101927746 accelerates progression of colorectal cancer via inhibiting miR-584-3p and activating SSRP1.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30616889","citation_count":17,"is_preprint":false},{"pmid":"31839745","id":"PMC_31839745","title":"SSRP1 influences colorectal cancer cell growth and apoptosis via the AKT pathway.","date":"2019","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31839745","citation_count":16,"is_preprint":false},{"pmid":"27525970","id":"PMC_27525970","title":"Blockage of SSRP1/Ets-1/Pim-3 signalling enhances chemosensitivity of nasopharyngeal carcinoma to docetaxel in vitro.","date":"2016","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/27525970","citation_count":16,"is_preprint":false},{"pmid":"29764934","id":"PMC_29764934","title":"Structure-specific recognition protein-1 (SSRP1) is an elongated homodimer that binds histones.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29764934","citation_count":14,"is_preprint":false},{"pmid":"36511897","id":"PMC_36511897","title":"Mir204 and Mir211 suppress synovial inflammation and proliferation in rheumatoid arthritis by targeting Ssrp1.","date":"2022","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/36511897","citation_count":14,"is_preprint":false},{"pmid":"11824977","id":"PMC_11824977","title":"High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.","date":"2002","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/11824977","citation_count":13,"is_preprint":false},{"pmid":"16498457","id":"PMC_16498457","title":"Coupling caspase cleavage and ubiquitin-proteasome-dependent degradation of SSRP1 during apoptosis.","date":"2006","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/16498457","citation_count":12,"is_preprint":false},{"pmid":"25374021","id":"PMC_25374021","title":"Protein Phosphatase 2C of Toxoplasma Gondii Interacts with Human SSRP1 and Negatively Regulates Cell Apoptosis.","date":"2014","source":"Biomedical and environmental sciences : BES","url":"https://pubmed.ncbi.nlm.nih.gov/25374021","citation_count":9,"is_preprint":false},{"pmid":"31949834","id":"PMC_31949834","title":"MiR-223 inhibits the proliferation, invasion and EMT of nasopharyngeal carcinoma cells by targeting SSRP1.","date":"2018","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31949834","citation_count":9,"is_preprint":false},{"pmid":"40344476","id":"PMC_40344476","title":"SSRP1/SLC3A2 Axis in Arginine Transport: A New Target for Overcoming Immune Evasion and Tumor Progression in Peripheral T-Cell Lymphoma.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/40344476","citation_count":7,"is_preprint":false},{"pmid":"33407499","id":"PMC_33407499","title":"DLG1-AS1 is activated by MYC and drives the proliferation and migration of hepatocellular carcinoma cells through miR-497-5p/SSRP1 axis.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/33407499","citation_count":7,"is_preprint":false},{"pmid":"35463672","id":"PMC_35463672","title":"The Current Status of SSRP1 in Cancer: Tribulation and Road Ahead.","date":"2022","source":"Journal of healthcare engineering","url":"https://pubmed.ncbi.nlm.nih.gov/35463672","citation_count":5,"is_preprint":false},{"pmid":"39653795","id":"PMC_39653795","title":"Pseudokinase TRIB3 stabilizes SSRP1 via USP10-mediated deubiquitination to promote multiple myeloma progression.","date":"2024","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/39653795","citation_count":5,"is_preprint":false},{"pmid":"35291495","id":"PMC_35291495","title":"SSRP1 affects the growth and apoptosis of gastric cancer cells through AKT pathway.","date":"2022","source":"Journal of medical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35291495","citation_count":3,"is_preprint":false},{"pmid":"34921031","id":"PMC_34921031","title":"SSRP1 Worsens Malignant Melanoma Progression by Activating MAPKs Pathway.","date":"2021","source":"Annals of clinical and laboratory science","url":"https://pubmed.ncbi.nlm.nih.gov/34921031","citation_count":3,"is_preprint":false},{"pmid":"40468947","id":"PMC_40468947","title":"A Novel ceRNA Axis LOC121818100/Novel-miR-400/SSRP1 Regulated Muscle Growth and Injury Repair in Sheep.","date":"2025","source":"Journal of cachexia, sarcopenia and muscle","url":"https://pubmed.ncbi.nlm.nih.gov/40468947","citation_count":3,"is_preprint":false},{"pmid":"41544858","id":"PMC_41544858","title":"Arachidonic acid analog AACOCF3 suppresses cPLA2-negative NSCLC cell proliferation by targeting SSRP1 to activate the IFNα/β pathway.","date":"2026","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41544858","citation_count":1,"is_preprint":false},{"pmid":"39615716","id":"PMC_39615716","title":"Evolution of the chromatin remodeling complex FACT: Functional analysis of SSRP1 and SPT16 in early anther development.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/39615716","citation_count":1,"is_preprint":false},{"pmid":"9385438","id":"PMC_9385438","title":"Characterisation of bovine structure-specific recognition protein 1 (SSRP1) cDNA.","date":"1997","source":"Biochemistry and molecular biology international","url":"https://pubmed.ncbi.nlm.nih.gov/9385438","citation_count":1,"is_preprint":false},{"pmid":"37084412","id":"PMC_37084412","title":"Histone chaperone SSRP1 is required for apoptosis inhibition and mitochondrial function in HCC via transcriptional promotion of TRAP1.","date":"2023","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/37084412","citation_count":0,"is_preprint":false},{"pmid":"39267240","id":"PMC_39267240","title":"Retraction: SSRP1 Promotes Colorectal Cancer Progression and is Negatively Regulated by miR-28-5p.","date":"2024","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39267240","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.08.22.609092","title":"Activation and Evasion of the FEAR Pathway by RNA Viruses","date":"2024-08-22","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.22.609092","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26600,"output_tokens":6805,"usd":0.090938,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15643,"output_tokens":4686,"usd":0.097683,"stage2_stop_reason":"end_turn"},"total_usd":0.188621,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"FACT complex is a heterodimer of human SPT16 (hSpt16) and SSRP1; it acts as a chromatin-specific transcription elongation factor, interacts with nucleosomes and histone H2A/H2B dimers, and promotes nucleosome disassembly to facilitate transcription elongation through chromatin templates in vitro. FACT activity is abrogated by covalently crosslinking nucleosomal histones.\",\n      \"method\": \"Biochemical purification, in vitro transcription reconstitution on chromatin templates, nucleosome binding assays, crosslinking experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro on chromatin, multiple orthogonal biochemical methods, foundational paper replicated by many subsequent studies\",\n      \"pmids\": [\"10421373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SSRP1 (as part of FACT, a heterodimer with hSpt16) forms a UV-activated kinase complex with CK2 that selectively phosphorylates p53 at Ser-392 in vitro. FACT alters the substrate specificity of CK2 such that it preferentially phosphorylates p53 over other CK2 substrates including casein. Phosphorylation by this complex enhances p53 transcriptional activity.\",\n      \"method\": \"Biochemical purification of UV-activated kinase complex, in vitro kinase assay, identification of complex components by mass spectrometry/sequencing\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase reconstitution with purified complex, multiple biochemical methods, confirmed in two papers (PMID 11239457 and 12393879)\",\n      \"pmids\": [\"11239457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"hSPT16 and SSRP1 interact via non-overlapping domains in vitro and in cells; binding of hSPT16 and SSRP1 to CK2 changes CK2 conformation to specifically target p53 Ser-392 over other substrates. UV irradiation induces assembly of the CK2·hSPT16·SSRP1 complex, increasing specificity of CK2 for p53 at Ser-392.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assays, domain mapping, in vitro kinase assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and in vitro binding with domain mapping, single lab but orthogonal methods\",\n      \"pmids\": [\"12393879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The FACT complex (SSRP1/Spt16 heterodimer) exhibits affinity and specificity for cisplatin-damaged DNA, binding the major 1,2-d(GpG) intrastrand adduct. The isolated SSRP1 subunit alone fails to form discrete high-affinity complexes with cisplatin-modified DNA, suggesting Spt16 primes SSRP1 for cisplatin-damaged DNA recognition by unveiling its HMG domain. The isolated HMG domain of SSRP1 alone is sufficient for specific binding to cisplatin-damaged DNA.\",\n      \"method\": \"Gel mobility shift assays (EMSA) with cisplatin-damaged DNA, testing FACT complex, isolated SSRP1, and isolated HMG domain\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding assays with multiple constructs and controls, single lab\",\n      \"pmids\": [\"11344167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CK2 phosphorylates maize SSRP1 at multiple C-terminal residues including two sites adjacent to the HMG box domain; this phosphorylation induces a conformational change in the HMG box region (detected by circular dichroism) and switches on recognition of UV-damaged DNA by SSRP1 (non-phosphorylated SSRP1 does not discriminate between UV-damaged and control DNA).\",\n      \"method\": \"In vitro kinase assay with CK2α, acetic acid-urea PAGE, mass spectrometry phosphosite mapping, circular dichroism, DNA binding assays with UV-damaged DNA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro phosphorylation with site mapping and structural/functional readout, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12571244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CK2 phosphorylates SSRP1 at serines 510, 657, and 688 in vitro; phosphorylation inhibits the nonspecific DNA-binding activity of SSRP1 and FACT. Ser-510 is the most critical site for this regulation. SSRP1 is also phosphorylated in cells in response to UV (but not gamma) irradiation.\",\n      \"method\": \"In vitro CK2 kinase assay, peptide array kinase assay, site-directed mutagenesis (S510A/S657A/S688A), EMSA DNA-binding assays, metabolic 32P-labeling in cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, functional DNA-binding assay, and in-cell confirmation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"15659405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"SSRP1 functions as a co-activator of p63 by direct physical interaction (in vitro and in cells); it binds p63γ through its central domain, and ectopic expression of full-length SSRP1 (but not deletion mutants) enhances p63γ-dependent transcription, G1 arrest, apoptosis, and expression of endogenous p53 target genes. SSRP1 co-occupies p53-responsive elements of MDM2 and p21 promoters with p63γ.\",\n      \"method\": \"Co-immunoprecipitation, in vitro GST pulldown, luciferase reporter assays, chromatin immunoprecipitation (ChIP), cell-based gain/loss-of-function\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, in vitro pulldown, ChIP, and functional reporter assays, single lab\",\n      \"pmids\": [\"12374749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SSRP1 interacts with SRF (serum response factor) through the MADS box of SRF and a basic region of SSRP1 (amino acids 489–542 adjacent to the HMG domain); this interaction dramatically increases the DNA-binding activity of SRF and results in synergistic transcriptional activation of SRF-dependent promoters. SSRP1 itself does not bind the CArG box.\",\n      \"method\": \"Yeast one-hybrid screen, co-immunoprecipitation in mammalian cells, EMSA, luciferase reporter assays, domain mapping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast one-hybrid, Co-IP in mammalian cells, EMSA, reporter assays; single lab with multiple methods\",\n      \"pmids\": [\"10336466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"CHD1 interacts in vivo with SSRP1 via an amino-terminal segment of CHD1 that does not include the chromodomain; CHD1 and SSRP1 co-localize in mammalian nuclei and at transcriptionally active regions of Drosophila polytene chromosomes.\",\n      \"method\": \"Co-immunoprecipitation (in vivo), immunocytochemistry/immunofluorescence co-localization\",\n      \"journal\": \"Chromosoma\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with domain mapping and co-localization, single lab\",\n      \"pmids\": [\"10199952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In yeast, the bipartite FACT analog composed of Cdc68 (Spt16), Pob3, and Nhp6 functionally recapitulates the vertebrate FACT complex; Nhp6 (the yeast functional analog of the SSRP1 HMG domain) associates with the CP complex and provides HMG box functions for transcription elongation. An artificial Pob3-Nhp6a fusion protein (mimicking SSRP1) restores both Pob3 and Nhp6a functions.\",\n      \"method\": \"Genetic epistasis (double mutant analysis), 6-azauracil sensitivity, protein fusion complementation, co-immunoprecipitation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with multiple double mutants and protein fusion complementation, single lab\",\n      \"pmids\": [\"11313475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Ssrp1 homozygous knockout in mice causes embryonic lethality at day 3.5, with preimplantation blastocysts defective for cell outgrowth/survival in vitro. This lethality is p53-independent (crosses with p53-null background do not rescue), establishing nonredundant, essential functions for SSRP1 in early cell viability.\",\n      \"method\": \"Gene targeting in mouse ES cells, germline transmission, embryo outgrowth assays, p53-null genetic background cross\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with clear phenotype, genetic epistasis with p53-null background, in vivo and ex vivo confirmation\",\n      \"pmids\": [\"12861016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SSRP1 has both SPT16-dependent and SPT16-independent roles in transcription regulation in human cells; approximately 1.3% of assayed genes are co-regulated by both SSRP1 and Spt16, while a distinct subset is regulated by SSRP1 alone. Both SSRP1 and Spt16 are required for progression of elongating RNA Pol II on the egr1 gene.\",\n      \"method\": \"Spotted microarray after siRNA knockdown of SSRP1 or Spt16, chromatin immunoprecipitation for elongating Pol II\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide expression profiling plus ChIP for mechanistic follow-up, single lab\",\n      \"pmids\": [\"17209051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SSRP1 physically interacts with the HR repair protein Rad54 both in vitro and in vivo; SSRP1 inhibits Rad54-promoted branch migration of Holliday junctions in vitro. Knockdown of SSRP1 increases HR frequency and Rad51/H2AX foci, while overexpression reduces HU-induced Rad51 foci, indicating SSRP1 suppresses inappropriate homologous recombination repair.\",\n      \"method\": \"Co-immunoprecipitation (in vivo), in vitro pulldown, branch migration assay with Holliday junctions, hprt recombination assay, immunofluorescence for Rad51/γH2AX foci, siRNA knockdown and overexpression\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro functional assay (branch migration) plus Co-IP and cell-based epistasis, single lab\",\n      \"pmids\": [\"19639603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SSRP1 (as a FACT subunit) binds the KSHV latent origin replication element and forms a complex with LANA at this origin; siRNA knockdown of SSRP1 significantly reduces the efficiency of LANA-dependent latent DNA replication.\",\n      \"method\": \"Biotinylated DNA pulldown/affinity purification to identify origin-binding proteins, Co-immunoprecipitation, siRNA knockdown with plasmid replication efficiency assay\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — DNA affinity pulldown, Co-IP, and functional replication assay after knockdown, single lab\",\n      \"pmids\": [\"19710137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SSRP1 is cleaved during apoptosis by caspase 3 and/or caspase 7 at the DQHD450 site, generating a truncated chromatin-associated form of FACT. The N-terminal cleavage product is subsequently degraded via the ubiquitin-proteasome pathway (stabilized by proteasome inhibitors and ubiquitylated in cells).\",\n      \"method\": \"In vitro caspase cleavage assay, site-directed mutagenesis of caspase site, proteasome inhibitor treatment, ubiquitylation assay in cells, cellular fractionation\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro caspase assay with mutagenesis, proteasome inhibitor, and ubiquitylation in cells; single lab with multiple methods\",\n      \"pmids\": [\"16498457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structure of the SSRP1 middle domain reveals tandem pleckstrin homology (PH) domains (PH1 with an extra conserved βαβ topology); the middle domain participates in DNA binding via a positively charged patch on its surface, but does not bind histones (negative result confirmed by pulldown assay).\",\n      \"method\": \"X-ray crystallography, DNA binding assays, histone pulldown assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with functional validation by binding assays; single lab but structure plus biochemistry\",\n      \"pmids\": [\"26687053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FACT components SUPT16H and SSRP1 suppress HIV-1 transcription and promote viral latency; SUPT16H (but not SSRP1) directly interacts with HIV-1 Tat protein, yet both are recruited to the HIV-1 LTR promoter. SUPT16H interferes with association of Cyclin T1 (a P-TEFb subunit) with the Tat-LTR axis. Depletion of either SSRP1 or SUPT16H spontaneously reverses HIV-1 latency.\",\n      \"method\": \"RNAi functional genomic screen, Co-immunoprecipitation, HIV-1 LTR reporter assay, ChIP, latency reversal assays in U1/HIV, J-LAT cells, and primary CD4+ T cell model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP, functional reporter and latency reversal assays with multiple cell models; single lab\",\n      \"pmids\": [\"26378236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SSRP1 is recruited to DNA single-strand break (SSB) sites in a PARP-dependent manner and is retained at damage sites via N-terminal interactions with XRCC1. SSRP1 (but not SPT16) is specifically required for chromatin decondensation and histone H2B exchange at SSB sites, which primes chromatin for efficient SSB repair and cell survival after ionizing radiation or MMS treatment.\",\n      \"method\": \"Live-cell imaging (laser microirradiation recruitment), co-immunoprecipitation, domain mutational analysis, siRNA knockdown with survival assay, histone exchange (FRAP), chromatin decondensation assay\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (live imaging, Co-IP, mutagenesis, FRAP, survival assays), clear mechanistic dissection of SSRP1 vs SPT16 roles\",\n      \"pmids\": [\"28416484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SSRP1 forms an elongated homodimer in solution (characterized by AUC and SAXS); homodimerization involves the PH2 region, the same surface used for heterodimerization with SPT16, suggesting homo- and heterodimerization are mutually exclusive. SSRP1 homodimerization promotes binding to both histones H2A-H2B and H3-H4 (isothermal titration calorimetry); disruption of homodimerization decreases histone-binding affinity.\",\n      \"method\": \"Analytical ultracentrifugation (AUC), small-angle X-ray scattering (SAXS), isothermal titration calorimetry (ITC), site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — biophysical structural characterization (AUC, SAXS) combined with thermodynamic binding assay (ITC) and mutagenesis; single lab but multiple rigorous methods\",\n      \"pmids\": [\"29764934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SSRP1 promotes replication origin assembly on somatic chromatin in Xenopus by evicting histone H1 via its N-terminal domain; histone H1 removal derepresses ORC and MCM chromatin binding, enabling efficient replication origin firing. SSRP1 protein decays at mid-blastula transition (MBT), and increased SSRP1 levels delay MBT and accelerate post-MBT cell cycle speed and embryo development.\",\n      \"method\": \"Xenopus laevis egg extract replication assays, chromatin fractionation, siRNA/antibody depletion of SSRP1 and H1, domain mutational analysis, embryo microinjection\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution in Xenopus extracts with domain mutant analysis, chromatin fractionation, and in vivo embryo experiments; multiple orthogonal approaches\",\n      \"pmids\": [\"32165637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Depletion of SSRP1 in human mesenchymal stem cells decreases expression of osteoblast-specific genes and downregulates Wnt pathway target genes, accompanied by decreased nuclear localization of active β-catenin, identifying a role for SSRP1 in promoting Wnt signaling pathway activity during osteoblast differentiation.\",\n      \"method\": \"siRNA knockdown in human MSCs, RNA-seq, Western blot for active β-catenin nuclear localization, differentiation assays\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-seq combined with protein localization data after knockdown; single lab, two orthogonal methods\",\n      \"pmids\": [\"27146025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TRIB3 directly interacts with SSRP1 and USP10, forming a TRIB3/USP10/SSRP1 ternary complex; USP10-mediated deubiquitination stabilizes SSRP1 protein, and TRIB3 enhances this deubiquitinating effect. A stapled peptide (SP-A) disrupts the TRIB3/USP10/SSRP1 complex and promotes SSRP1 degradation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, in vivo and in vitro interaction studies, peptide disruption assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with mechanistic follow-up (ubiquitination assay and pharmacological disruption), single lab\",\n      \"pmids\": [\"39653795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"SSRP1 (identified as PREIIBF) binds with sequence specificity to a 19-bp positive regulatory element (PRE II) in the human embryonic ε-globin gene promoter, bends the target DNA, and is required for promoter activation in stable erythroid cell lines. This is the first evidence that SSRP1 plays a direct role in transcriptional regulation via sequence-specific DNA binding.\",\n      \"method\": \"cDNA expression cloning, EMSA (gel shift with specific DNA competition), DNA bending assay (circularization), stable transfection reporter assay in erythroid cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA with competition controls, DNA bending assay, stable cell reporter assay; single lab with multiple methods\",\n      \"pmids\": [\"9566881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SSRP1 maintains mitochondrial oxidative respiration in hepatocellular carcinoma cells by transcriptionally promoting expression of TRAP1 (the mitochondrial HSP90 family member); SSRP1 occupies the TRAP1 promoter (by ChIP), and SSRP1 knockdown decreases TRAP1 mRNA and protein, reduces mitochondrial oxidative respiration, and causes mitochondrial damage.\",\n      \"method\": \"siRNA knockdown, ChIP assay, qRT-PCR, Western blot, mitochondrial respiration assay (Seahorse), rescue experiments\",\n      \"journal\": \"Biochemistry and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus functional rescue experiments confirming transcriptional mechanism; single lab\",\n      \"pmids\": [\"37084412\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The FACT complex (hSpt16/SSRP1) mediates the FEAR (FACT-ETS-1 Antiviral Response) pathway, remodeling chromatin to activate expression of the antiviral transcription factor ETS-1 to restrict RNA virus (VSV and paramyxovirus) replication. VSV M protein promotes proteasome-dependent degradation of SUMOylated hSpt16 to counter FEAR; this antagonism of SUMOylated Spt16 by viral proteins is a conserved mechanism across DNA and RNA viruses.\",\n      \"method\": \"siRNA depletion of hSpt16/SSRP1, viral replication assays, mutant M protein analysis, genetic rescue experiments\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with defined replication phenotype, mutant virus rescue, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2024.08.22.609092\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"SSRP1 is an essential histone chaperone subunit of the FACT complex (heterodimer with SPT16) that facilitates chromatin transcription elongation and replication by interacting with nucleosomes and H2A/H2B dimers to promote nucleosome disassembly; it also forms an elongated homodimer (via its PH2 domain) capable of binding H2A-H2B and H3-H4 independently of SPT16, participates in DNA single-strand break repair through PARP-dependent recruitment and XRCC1 interaction at damage sites, suppresses inappropriate homologous recombination by inhibiting Rad54-mediated branch migration, promotes replication origin assembly in vertebrate embryos by evicting histone H1 via its N-terminal domain, modulates p53 Ser-392 phosphorylation by altering CK2 substrate specificity (with CK2-mediated phosphorylation of SSRP1 itself at Ser-510/657/688 inhibiting its DNA-binding activity), acts as a co-activator of p63 and SRF transcription factors through direct protein interactions, suppresses HIV-1 and HTLV-1 transcription as part of the FACT-ETS-1 (FEAR) antiviral pathway, and is degraded during apoptosis by sequential caspase-3/7 cleavage at Asp-450 followed by ubiquitin-proteasome-mediated proteolysis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SSRP1 is an essential histone chaperone that, as one subunit of the heterodimeric FACT complex with SPT16, binds nucleosomes and histone H2A/H2B dimers to drive nucleosome disassembly and facilitate RNA polymerase II elongation through chromatin [#0, #11]. Its essentiality is intrinsic and p53-independent: homozygous loss is lethal at the mouse blastocyst stage [#10]. The protein is built from defined modules — a middle region of tandem pleckstrin-homology domains that contributes DNA binding but not histone binding [#15], and a PH2 surface that mediates either heterodimerization with SPT16 or, mutually exclusively, formation of an elongated SSRP1 homodimer that binds both H2A-H2B and H3-H4 independently of SPT16 [#18]. Beyond transcription elongation, SSRP1 carries out SPT16-independent chromatin functions: it is recruited to DNA single-strand breaks in a PARP-dependent manner, retained through N-terminal XRCC1 interactions, and required for chromatin decondensation and H2B exchange that prime single-strand break repair [#17]; it suppresses inappropriate homologous recombination by binding Rad54 and inhibiting Holliday-junction branch migration [#12]; and it promotes replication origin assembly by evicting histone H1 via its N-terminal domain to derepress ORC/MCM loading [#19]. SSRP1 also acts in transcription factor–directed gene control, serving as a co-activator of p63 [#6] and SRF [#7] and as a sequence-specific activator of the embryonic ε-globin promoter [#22], and it modulates p53 by reprogramming CK2 substrate specificity toward p53 Ser-392, while reciprocal CK2 phosphorylation of SSRP1 at Ser-510/657/688 inhibits its DNA binding [#1, #5]. The protein is regulated by competing post-translational programs: caspase-3/7 cleavage at Asp-450 followed by ubiquitin-proteasome degradation during apoptosis [#14], and USP10-mediated deubiquitination within a TRIB3/USP10/SSRP1 complex that stabilizes it [#21]. Through its FACT-resident chromatin-remodeling activity, SSRP1 additionally participates in antiviral and viral-replication control, restricting HIV-1 transcription and supporting KSHV latent replication [#16, #13].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established that SSRP1 can act directly in transcription through sequence-specific DNA binding, before its chromatin chaperone role was defined.\",\n      \"evidence\": \"cDNA cloning, EMSA, DNA bending, and erythroid reporter assays at the ε-globin PRE II element\",\n      \"pmids\": [\"9566881\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Does not connect sequence-specific binding to the later-defined FACT nucleosome activity\", \"No structural basis for PRE II recognition\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defined SSRP1 as half of the FACT heterodimer that disassembles nucleosomes to enable transcription elongation, the core function of the protein.\",\n      \"evidence\": \"Biochemical purification and in vitro transcription reconstitution on chromatin with nucleosome binding and crosslinking assays\",\n      \"pmids\": [\"10421373\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which subunit contacts which histone surface\", \"In vitro chromatin templates only\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified SSRP1 partnerships beyond SPT16, linking it to SRF-dependent transcription and to the remodeler CHD1.\",\n      \"evidence\": \"Yeast one-hybrid, Co-IP, EMSA, reporter assays (SRF) and in vivo Co-IP with co-localization (CHD1)\",\n      \"pmids\": [\"10336466\", \"10199952\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether these interactions occur within FACT or via free SSRP1 unresolved\", \"No structural model of the SRF or CHD1 contact\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Revealed that SSRP1/FACT reprograms CK2 substrate specificity toward p53 Ser-392 and recognizes damaged DNA, expanding its role into the DNA-damage/p53 axis.\",\n      \"evidence\": \"UV-activated kinase complex purification with in vitro kinase assays; EMSA with cisplatin-damaged DNA using FACT, isolated SSRP1, and the HMG domain\",\n      \"pmids\": [\"11239457\", \"11344167\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro kinase context only\", \"Functional consequence of damaged-DNA binding for repair not directly tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Mapped the molecular logic of FACT subunit interaction and CK2 conformational steering, and established SSRP1 as a p63 transcriptional co-activator.\",\n      \"evidence\": \"Domain-mapped Co-IP and in vitro kinase assays (CK2 complex); reciprocal Co-IP, GST pulldown, ChIP, and reporter/phenotype assays (p63γ)\",\n      \"pmids\": [\"12393879\", \"12374749\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab interaction mapping\", \"Endogenous stoichiometry of the CK2·SPT16·SSRP1 complex unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated SSRP1 is genetically essential for early embryonic viability independent of p53, separating its core function from its p53-modulating role.\",\n      \"evidence\": \"Mouse gene targeting, embryo outgrowth assays, and crosses to a p53-null background\",\n      \"pmids\": [\"12861016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Lethality precludes assignment to a single molecular process\", \"Which essential activity (elongation vs replication) drives lethality not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established reciprocal regulation: CK2 phosphorylation of SSRP1 at Ser-510/657/688 inhibits its DNA-binding activity, a UV-responsive control point.\",\n      \"evidence\": \"In vitro CK2 kinase assays, site-directed mutagenesis, EMSA, and in-cell 32P labeling (with supporting maize data on HMG-adjacent phosphosites)\",\n      \"pmids\": [\"15659405\", \"12571244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cellular consequences of phospho-inhibition for transcription/repair not directly tested\", \"Cross-species site correspondence inferred\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed SSRP1 is dismantled during apoptosis by ordered caspase cleavage and proteasomal degradation, linking FACT inactivation to cell death.\",\n      \"evidence\": \"In vitro caspase cleavage with site mutagenesis, proteasome inhibitor and ubiquitylation assays, and fractionation\",\n      \"pmids\": [\"16498457\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of the truncated chromatin-bound form not defined\", \"Which apoptotic signals trigger this in vivo unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Distinguished SPT16-dependent from SPT16-independent SSRP1 transcriptional functions genome-wide.\",\n      \"evidence\": \"Microarray after siRNA of SSRP1 or Spt16 plus ChIP for elongating Pol II on egr1\",\n      \"pmids\": [\"17209051\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of SSRP1-only gene regulation not resolved\", \"Direct vs indirect targets not separated\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended SSRP1 into genome maintenance and viral DNA replication: suppression of homologous recombination via Rad54 and support of KSHV latent origin replication.\",\n      \"evidence\": \"Co-IP and in vitro branch-migration assay with recombination/foci readouts (Rad54); DNA affinity pulldown, Co-IP, and replication assays (KSHV origin/LANA)\",\n      \"pmids\": [\"19639603\", \"19710137\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HR suppression requires FACT or free SSRP1 unclear\", \"Single-lab functional assays\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Provided structural and biophysical definition of SSRP1 architecture: a DNA-binding tandem-PH middle domain and a PH2-mediated homodimer that binds histones independently of SPT16.\",\n      \"evidence\": \"X-ray crystallography with DNA/histone binding assays; AUC, SAXS, ITC, and mutagenesis\",\n      \"pmids\": [\"26687053\", \"29764934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo prevalence and function of the homodimer not established\", \"How homo/heterodimer switching is controlled in cells unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined an SPT16-independent role for SSRP1 in single-strand break repair, recruited via PARP and retained by XRCC1 to remodel chromatin for repair.\",\n      \"evidence\": \"Laser microirradiation live imaging, Co-IP, domain mutants, FRAP histone exchange, and survival assays\",\n      \"pmids\": [\"28416484\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs PARP-bridged SSRP1–XRCC1 contact not fully resolved\", \"Relationship to FACT elongation activity unclear\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed SSRP1 promotes replication origin assembly by N-terminal eviction of histone H1, derepressing ORC/MCM loading and timing developmental cell-cycle transitions.\",\n      \"evidence\": \"Xenopus egg-extract replication assays, chromatin fractionation, depletion, domain mutants, and embryo microinjection\",\n      \"pmids\": [\"32165637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mammalian somatic origins use the same H1-eviction mechanism untested\", \"Selectivity of H1 over other linker histones not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified post-translational stabilization of SSRP1 through a TRIB3/USP10 deubiquitination complex, and broadened its FACT-dependent antiviral role through the FEAR/ETS-1 pathway.\",\n      \"evidence\": \"Co-IP, ubiquitination and peptide-disruption assays (TRIB3/USP10); siRNA depletion, viral replication, and mutant M-protein rescue (FEAR, preprint)\",\n      \"pmids\": [\"39653795\", \"bio_10.1101_2024.08.22.609092\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"FEAR finding is a non-peer-reviewed preprint\", \"Whether SSRP1 vs SPT16 drives FEAR chromatin remodeling not separated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how SSRP1 partitions between its FACT-bound elongation role, its SPT16-independent repair/replication/homodimer activities, and its many transcription-factor co-activator functions within a single cell.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No in vivo measurement of the relative abundance of FACT heterodimer vs SSRP1 homodimer\", \"No unified model linking phospho-regulation, dimer state, and functional choice\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0, 18]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [3, 15, 22]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [6, 7, 22, 23]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [0, 17]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 11]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [12, 17]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [19]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 17, 19]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"complexes\": [\"FACT complex\"],\n    \"partners\": [\"SUPT16H\", \"CSNK2A1\", \"XRCC1\", \"RAD54\", \"TP63\", \"SRF\", \"CHD1\", \"USP10\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}